17.06
Spyre Therapeutics Inc (SYRE) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
-
|
- | - | - | - |
Operating Expenses |
21.71%
41.94
|
53.57 | 55.39 | 44.15 | 47.77 |
Operating Income/Loss |
21.71%
-41.94
|
-53.57 | -55.39 | -44.15 | -47.77 |
Nonoperating Income/Loss |
40.56%
5.218
|
8.779 | -13.62 | 5.31 | 3.949 |
Income/Loss From Continuing Operations Before Tax |
18.02%
-36.72
|
-44.79 | -69.01 | -38.84 | -43.83 |
Income Tax Expense/Benefit |
100.00%
-
|
-0.015 | 0.018 | - | 0.032 |
Income/Loss From Continuing Operations After Tax |
17.99%
-36.72
|
-44.77 | -69.03 | -38.84 | -43.86 |
|
17.99%
-36.72
|
-44.77 | -69.03 | -38.84 | -43.86 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):